National Cancer Institute National Cancer Institute
U.S. National Institutes of Health National Cancer Institute
NCI Home Cancer Topics Clinical Trials Cancer Statistics Research & Funding News About NCI
Childhood Extracranial Germ Cell Tumors Treatment (PDQ®)
Patient VersionHealth Professional VersionEn españolLast Modified: 02/26/2008
Table 4: Type of Germ Cell Tumor by Stage and by Risk Group*

  Ovarian  Testicular  Extragonadal 
Stage I Low Low Intermediate
Stage II Intermediate Intermediate Intermediate
Stage III Intermediate Intermediate High
Stage IV High** Intermediate*** High

*Adapted from Rogers PC et al.[6] and Cushing B et al.[7]
**Stage IV ovarian tumors in children and adolescents continue to be treated with four courses of pediatric PEB; these patients are not eligible for either a possible reduction in treatment courses, as are the intermediate-risk patients, or the high-risk protocol that includes the potential of greater toxicity.
***Stage IV testicular tumors in patients older than 15 years should be staged according to adult guidelines. For more information, please refer to the PDQ summary Testicular Cancer Treatment.

References

  1. Rogers PC, Olson TA, Cullen JW, et al.: Treatment of children and adolescents with stage II testicular and stages I and II ovarian malignant germ cell tumors: A Pediatric Intergroup Study--Pediatric Oncology Group 9048 and Children's Cancer Group 8891. J Clin Oncol 22 (17): 3563-9, 2004.  [PUBMED Abstract]

  2. Cushing B, Giller R, Cullen JW, et al.: Randomized comparison of combination chemotherapy with etoposide, bleomycin, and either high-dose or standard-dose cisplatin in children and adolescents with high-risk malignant germ cell tumors: a pediatric intergroup study--Pediatric Oncology Group 9049 and Children's Cancer Group 8882. J Clin Oncol 22 (13): 2691-700, 2004.  [PUBMED Abstract]


A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov